Last updated 2026-07-20
- Raised $1.9B Undisclosed Round, Aug 2025
- Raised $4.3B Undisclosed Round, Oct 2023
- Raised $3.5B Undisclosed Round, Mar 2021
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
OrbiMed is a leading global healthcare investment firm with approximately $20 billion in assets under management. The firm invests across the global healthcare industry, from seed-stage venture capital to large publicly-traded companies, through private equity funds, public equity funds, and royalty/credit funds. OrbiMed's investment advisory business was founded in 1989 with a vision to invest across the spectrum of healthcare companies. They have offices in New York City, London, San Francisco, Shanghai, Hong Kong, Mumbai, and Herzliya, Israel.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
Portfolio by sector
Undisclosed1
Health Tech & Life Sciences1
Q&A
- What is OrbiMed Healthcare Fund Management's primary investment focus?
- OrbiMed Healthcare Fund Management primarily invests in the Health Tech & Life Sciences sector, as evidenced by its portfolio companies like RDD Pharma and SmartZyme Biopharma.
- Can you name some of OrbiMed Healthcare Fund Management's portfolio companies?
- OrbiMed Healthcare Fund Management's portfolio includes RDD Pharma, which focuses on treating anorectal diseases.
- When did OrbiMed Healthcare Fund Management make its most recent known investment?
- OrbiMed Healthcare Fund Management made a known investment in January 2016.
- What was one of OrbiMed Healthcare Fund Management's earlier investments?
- OrbiMed Healthcare Fund Management made an investment in July 2012.
- What is the typical investment range for OrbiMed Healthcare Fund Management?
- OrbiMed Healthcare Fund Management's investment range is between $6.5M and $7.15M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1989 |
|---|